Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1838262 in migraine prophylaxis
NCT00742209Phase 2Completed
- Sponsor
- XenoPort, Inc.
- Start
- Aug 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of gabapentin enacarbil in migraine, sponsored by XenoPort, Inc.. Started Aug 2008; status: completed.
02
Drugs
gabapentin enacarbil
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00742209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742209.